Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor

Journal of Immunology

Volumn 169, Issue 11, 2002, Pages 6474-6481

  Marrache, A Marilise ^a,b   Gobeil Jr , Fernand ^b   Bernier, Sylvie G ^b   Stankova, Jana ^c   Rola Pleszczynski, Marek ^c   Choufani, Sanaa ^c   Bkaily, Ghassan ^c   Bourdeau, Annie ^d   Sirois, Martin G ^d   Vazquez Tello, Alejandro ^b   Fan, Li ^b   Joyal, Jean Sébastien ^b   Filep, Janos G ^e   Varma, Daya R ^a   Ribeiro da Silva, Alfredo ^a   Chemtob, Sylvain ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d MONTREAL HEART INSTITUTE   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARBAMIC ACID METHYL ESTER; CELL NUCLEUS RECEPTOR; CYCLIC AMP; CYCLOOXYGENASE 2; DNA; HYDROGEN PEROXIDE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE SYNTHASE; PERTUSSIS TOXIN; PROTEIN INHIBITOR; RADIOLIGAND; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; AUTACOID; CELL SURFACE RECEPTOR; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; MESSENGER RNA; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARTICLE; BINDING SITE; BRAIN CELL; CELL NUCLEUS; CELL SURFACE; CELLULAR DISTRIBUTION; CHO CELL; CONFOCAL MICROSCOPY; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE INDUCTION; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; INFLAMMATION; LIGAND BINDING; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ANIMAL; CELL CULTURE; ELECTRON MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; METABOLISM; SIGNAL TRANSDUCTION; SWINE; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ANIMALS; BINDING SITES; CELL NUCLEUS; CELLS, CULTURED; CHO CELLS; CONSENSUS SEQUENCE; CRICETINAE; CYCLOOXYGENASE 2; DNA; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION MEDIATORS; ISOENZYMES; MICROSCOPY, ELECTRON; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; SWINE;

EID: 0036884098     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.11.6474     Document Type: Article

References (64)

1. Montrucchio, G., G. Alloatti, and G. Camussi. 2000. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev. 80:1669.
2. Agrawal, D. K., N. Ali, and T. Numao. 1992. PAF receptors and G-proteins in human blood eosinophils and neutrophils. J. Lipid Mediators 5:101.
3. Lin, A. Y., and Y. C. Rui. 1994. Platelet-activating factor induces calcium mobilization and phosphoinositide metabolism in cultured bovine cerebral microvascular endothelial cells. Biochim. Biophys. Acta 1224:323.
4. i1/2, mediate platelet-activating factor-stimulated phosphoinositide metabolism in immortalized hippocampal cells. J. Neurochem. 67:1478.
5. Marcheselli, V. L., M. J. Rossowska, M. T. Domingo, P. Braquet, and N. G. Bazan. 1990. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J. Biol. Chem. 265:9140.
6. Pierce, K. L., L. M. Lutrell, and R. J. Lefkowitz. 2001. New mechanisms in heptahelical receptor signaling to mitogen activated protein cascades. Oncogene 20:1532.
7. Bussolino, F., and G. Camussi. 1995. Platelet-activating factor produced by endothelial cells: a molecule with autocrine and paracrine properties. Eur. J. Biochem. 229:327.
8. Bazan, N. G. 1998. The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog. Brain Res. 118:281.
9. Liu, X. H., B. L. Eun, and J. D. Barks. 2001. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr. Res. 49:804.
10. Whatley, R. E., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1988. Endothelium from diverse vascular sources synthesizes platelet-activating factor. Arteriosclerosis 8:321.
11. Lynch, J. M., and P. M. Henson. 1986. The intracellular retention of newly synthesized platelet-activating factor. J. Immunol. 137:2653.
12. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270:30749.
13. Baker, R. R., and H. Chang. 1996. Alkylglycerophosphate acetyltransferase and lyso platelet activating factor acetyltransferase, two key enzymes in the synthesis of platelet activating factor, are found in neuronal nuclei isolated from cerebral cortex. Biochim. Biophys. Acta 1302:257.
14. sα in S49 lymphoma cells. FASEB J. 8:252.
15. i. FASEB J. 11:189.
16. Gerasimenko, O. V., J. V. Gerasimenko, A. V. Tepikin, and O. H. Petersen. 1996. Calcium transport pathways in the nucleus. Pflügers Arch. 432:1.
17. Szewczyk, A. 1998. The intracellular potassium and chloride channels: properties, pharmacology and function. Mol. Membr. Biol. 15:49.
18. qα-dependent activation, particulate association, and nuclear localization of phospholipase C-β1. J. Biol. Chem. 271:21187.
19. Yamamoto, S., K. Kawamura, and T. N. James. 1998. Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microsc. Res. Tech. 40:479.
20. D'Santos, C. S., J. H. Clarke, and N. Divecha. 1998. Phospholipid signalling in the nucleus. Biochim. Biophys. Acta 1436:201.
21. Carlotti, F., S. K. Dower, and E. E. Qwarnstrom. 2000. Dynamic shuttling of nuclear factor κB between the nucleus and cytoplasm as a consequence of inhibitor dissociation. J. Biol. Chem. 275:41028.
22. Szabo, C., C.-C. Wu, J. A. Mitchell, S, S. Gross, C. Thiemermann, and J. R. Vane. 1993. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ. Res. 73:991.
23. 2 α on retinal vessels. Am. J. Physiol. 274:R1406.
24. Parent, J. L., C. Le Gouill, A. J. de Brum-Fernandes, M. Rola-Pleszczynski, and J. Stankova. 1996. Mutations of two adjacent amino acids generate inactive and constitutively active forms of the human platelet-activating factor receptor. J. Biol. Chem. 271:7949.
25. 3 receptors. Circ. Res. 90:682.
26. Nishida, K., and S. P. Markey. 1996. Platelet-activating factor in brain regions after transient ischemia in gerbils. Stroke 27:514.
27. O'Flaherty, J. T., J. F. Redman, Jr., J. D. Schmitt, J. M. Ellis, J. R. Surles, M. H. Marx, C. Piantadosi, and R. L. Wykle. 1987. 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: a biologically potent, non-metabolizable analog of platelet-activating factor. Biochem. Biophys. Res. Commun. 147:18.
28. Ihida, K., D. Predescu, R.-P. Czekay, and G. E. Palade. 1999. Platelet activating factor receptor (PAF-R) is found in a large endosomal compartment in human umbilical vein endothelial cells. J. Cell Sci. 112:285.
29. 4 in the nuclear envelope. J. Biol. Chem. 274:15719.
30. McLeod, A, L., J. E. Krause, A. C. Cuello, and A. Ribeiro-da-Silva. 1998. Preferential synaptic relationships between substance P-immunoreactive boutons and neurokinin 1 receptor sites in the rat spinal cord. Proc. Natl. Acad. Sci. USA 95:15775.
31. 2α receptor density in brain microvessels of pigs. Br. J. Pharmacol. 112:59.
32. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440.
33. Summers, J. B., and D. H. Albert. 1995. Platelet activating factor antagonists. Adv. Pharmacol. 32:67.
34. Ishii, I., T. Izumi, H. Tsukamoto, H. Umeyama, M. Ui, and T. Shimizu. 1997. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants. J. Biol. Chem. 272:7846.
35. Peri, K. G., P. Hardy, D. You Li, D. R. Varma, and S. Chemtob. 1995. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J. Biol. Chem. 41:24615.
36. 2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem. Biophys. Res. Commun. 271:812.
37. 2 by exogenous hydrogen peroxide. Biochem. Pharmacol. 50:753.
38. Hwang, S. B. 1990. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J. Lipid Mediators 2:123.
39. Rodriguez, C. G., D. R. Cundell, E. I. Tuomanens, L. F. Kolakowski, Jr., C. Gerard, and N. P. Gerard. 1995. The role of N-glycosylation for functional expression of the human platelet-activating factor receptor: glycosylation is required for efficient membrane trafficking. J. Biol. Chem. 270:25178.
40. 32P]trisphosphate binding to isolated rat liver nuclei: evidence for inositol trisphosphate receptor-mediated calcium release from the nucleus. Proc. Natl. Acad. Sci. USA 87:9270.
41. Thomson, S., L. C. Mahadevan, and A. L. Clayton. 1999. MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction. Semin. Cell Dev. Biol. 10:205.
42. Miike, S., K. Kurasawa, Y. Saito, and I. Iwamoto. 2000. Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils. J. Leukocyte Biol. 67:117.
43. Garcia-Garcia, E., G. Sanchez-Mejorada, and C. Rosales. 2001. Phosphatidylinositol 3-kinase and ERK are required for NF-κB activation but not for phagocytosis. J. Leukocyte Biol. 70:649.
44. Kosaka, T., A. Miyata, H. Ihara, S. Hara, T. Sugimoto, O. Takeda, E. Takahashi, and T. Tanabe. 1994. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur. J. Biochem. 221:889.
45. Larkin, J. M., W. C. Donzell, and R. G. Anderson. 1985. Modulation of intracellular potassium and ATP: effects on coated pit function in fibroblasts and hepatocytes. J. Cell. Physiol. 124:372.
46. 2 receptors. Proc. Natl. Acad. Sci. USA 95:15792.
47. Ventura, C. P., J. Wolchock, M. L. Hull, and S. M. Howell. 1998. Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei. J. Biol. Chem. 273:13383.
48. Bkaily, G., P. Pothier, P. D'Orleans-Juste, M. Simaan, D. Jacques, D. Jaalouk, F. Belzile, G. Hassan, C. Boutin, G. Haddad, and W. Neugebauer. 1997. The use of confocal microscopy in the investigation of cell structure and function in the heart, endothelium and smooth muscle cells. Mol. Cell. Biochem. 172:171.
49. Massfelder, T., P. Dann, T. L. Wu, R. Vasavada, J. J. Helwig, and A. F. Stewart. 1997. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc. Natl. Acad. Sci. USA 94:13630.
50. Eggena, P., J. H. Zhu, K. Clegg, and J. D. Barrett. 1993. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 22:496.
51. Aarts, M. M., A. Rix, J. Guo, R. Bringhurst, and J. E. Henderson. 1999. The nucleolar targeting signal (NTS) of parathyroid hormone related protein mediates endocytosis and nucleolar translocation. J. Bone Miner. Res. 14:1493.
52. Hornick, C. A., C. T. Anthony, S. Hughey, B. M. Gebhardt, G. D. Espenan, and E. A. Woltering. 2000. Progressive nuclear translocation of somatostatin analogs. J. Nucl. Med. 41:1256.
53. Lu, D., H. Yang, G. Shaw, and M. K. Raizada. 1998. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139:365.
54. Chase, P. B., M. Halonen, and J. W. Regan. 1993. Cloning of a human platelet-activating factor receptor gene: evidence for an intron in the 5′-untranslated region. Am. J. Respir. Cell Mol. Biol. 8:240.
55. Teasdale, R. D., and M. R. Jackson. 1996. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu. Rev. Cell. Dev. Biol. 12:27.
56. Chen, R., Y. V. Mukhin, M. N. Garnovskaya, T. E. Thielen, Y. Iijima, C. Huang, J. R. Raymond, M. E. Ullian, and R. V. Paul. 2000. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am. J. Renal Physiol. 279:F440.
57. Le Gouill, C., J. L. Parent, M. Rola-Pleszczynski, and J. Stankova. 1997. Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor. J. Biol. Chem. 272:21289.
58. Cieslik, K., C. S. Abrams, and K. K. Wu. 2001. Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase γ/Janus kinase 2/MEK-1-dependent pathway. J. Biol. Chem. 276:1211.
59. Kim, S. J., and C. R. Kahn. 1997. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression. Biochem. J. 323:621.
60. Kravchenko, V. V., Z. Pan, J. Han, J.-M. Herbert, R. J. Ulevitch, and R. D. Ye. 1995. Platelet-activating factor induces NF-κB through a G protein-coupled pathway. J. Biol. Chem. 270:14928.
61. Tsuyuki, K., G. Ichinowatari, A. Tanimoto, M. Yamada, H. Yaginuma, and K. Ohuchi. 2002. Possible participation of intracellular platelet-activating factor in NF-κB activation in rat peritoneal macrophages. Biochim. Biophys. Acta 1583:26.
62. Karin, M., and Y. Ben-Nariah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621.
63. Sachdev, S., A. Hoffmann, and M. Hannink. 1998. Nuclear localization of IκBα is mediated by the second ankyrin repeat: the IκBα ankyrin repeats define a novel class of cis-acting nuclear import sequences. Mol. Cell. Biol. 18:2524.
64. Bevers, E. M., P. Comfurius, D. W. Dekkers, and R. F. Zwaal. 1999. Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta 1439:317.